787 related articles for article (PubMed ID: 25008267)
1. The tumour microenvironment in B cell lymphomas.
Scott DW; Gascoyne RD
Nat Rev Cancer; 2014 Aug; 14(8):517-34. PubMed ID: 25008267
[TBL] [Abstract][Full Text] [Related]
2. Role of the tumor microenvironment in mature B-cell lymphoid malignancies.
Fowler NH; Cheah CY; Gascoyne RD; Gribben J; Neelapu SS; Ghia P; Bollard C; Ansell S; Curran M; Wilson WH; O'Brien S; Grant C; Little R; Zenz T; Nastoupil LJ; Dunleavy K
Haematologica; 2016 May; 101(5):531-40. PubMed ID: 27132279
[TBL] [Abstract][Full Text] [Related]
3. Targeting the tumor microenvironment in B-cell lymphoma: challenges and opportunities.
Liu Y; Zhou X; Wang X
J Hematol Oncol; 2021 Aug; 14(1):125. PubMed ID: 34404434
[TBL] [Abstract][Full Text] [Related]
4. Microenvironment signaling driving lymphomagenesis.
Verdière L; Mourcin F; Tarte K
Curr Opin Hematol; 2018 Jul; 25(4):335-345. PubMed ID: 29746265
[TBL] [Abstract][Full Text] [Related]
5. Shaping of the tumor microenvironment: Stromal cells and vessels.
Blonska M; Agarwal NK; Vega F
Semin Cancer Biol; 2015 Oct; 34():3-13. PubMed ID: 25794825
[TBL] [Abstract][Full Text] [Related]
6. [The immune microenvironment in malignant lymphoma].
Nishikori M
Rinsho Ketsueki; 2019; 60(9):1229-1235. PubMed ID: 31597848
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy in aggressive B-cell lymphomas.
Jacobson CA; Armand P
Best Pract Res Clin Haematol; 2018 Sep; 31(3):299-305. PubMed ID: 30213400
[TBL] [Abstract][Full Text] [Related]
8. The challenge of the microenvironment in B-cell lymphomas.
Coupland SE
Histopathology; 2011 Jan; 58(1):69-80. PubMed ID: 21261684
[TBL] [Abstract][Full Text] [Related]
9. Role of the microenvironment across histological subtypes of NHL.
Tarte K
Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):610-617. PubMed ID: 29222311
[TBL] [Abstract][Full Text] [Related]
10. Intimate cross-talk between cancer cells and the tumor microenvironment of B-cell lymphomas: The key role of exosomes.
Xu B; Wang T
Tumour Biol; 2017 Jun; 39(6):1010428317706227. PubMed ID: 28618932
[TBL] [Abstract][Full Text] [Related]
11. Genetically Engineered Mouse Models Support a Major Role of Immune Checkpoint-Dependent Immunosurveillance Escape in B-Cell Lymphomas.
Lemasson Q; Akil H; Feuillard J; Vincent-Fabert C
Front Immunol; 2021; 12():669964. PubMed ID: 34113345
[TBL] [Abstract][Full Text] [Related]
12. The microenvironment in lymphomas--dissecting the complex crosstalk between tumor cells and 'by-stander' cells.
Rosenquist R; Davi F; Ghia P
Semin Cancer Biol; 2014 Feb; 24():1-2. PubMed ID: 24365642
[TBL] [Abstract][Full Text] [Related]
13. Tumor Metabolism as a Regulator of Tumor-Host Interactions in the B-Cell Lymphoma Microenvironment-Fueling Progression and Novel Brakes for Therapy.
Beielstein AC; Pallasch CP
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31454887
[TBL] [Abstract][Full Text] [Related]
14. Novel insights into the disease dynamics of B-cell lymphomas in the Genomics Era.
Chan FC; Lim E; Kridel R; Steidl C
J Pathol; 2018 Apr; 244(5):598-609. PubMed ID: 29359812
[TBL] [Abstract][Full Text] [Related]
15. The immune landscape and response to immune checkpoint blockade therapy in lymphoma.
Kline J; Godfrey J; Ansell SM
Blood; 2020 Feb; 135(8):523-533. PubMed ID: 31790142
[TBL] [Abstract][Full Text] [Related]
16. The tumor microenvironment of lymphomas: Insights into the potential role and modes of actions of checkpoint inhibitors.
Menter T; Tzankov A; Dirnhofer S
Hematol Oncol; 2021 Feb; 39(1):3-10. PubMed ID: 33105031
[TBL] [Abstract][Full Text] [Related]
17. Microvessel density and expression of vascular endothelial growth factor and its receptors in different subtypes of primary cutaneous B-cell lymphoma.
Wobser M; Siedel C; Kneitz H; Bröcker EB; Goebeler M; Houben R; Geissinger E
Acta Derm Venereol; 2013 Nov; 93(6):656-62. PubMed ID: 23624620
[TBL] [Abstract][Full Text] [Related]
18. Thymidine phosphorylase expression in B-cell lymphomas and its significance: a new prognostic marker?
Nie X; Clifford PM; Bhat R; Heintzelman R; Abraham M; Hou JS
Anal Quant Cytopathol Histpathol; 2013 Dec; 35(6):301-5. PubMed ID: 24617035
[TBL] [Abstract][Full Text] [Related]
19. Origin and pathogenesis of B cell lymphomas.
Seifert M; Scholtysik R; Küppers R
Methods Mol Biol; 2013; 971():1-25. PubMed ID: 23296955
[TBL] [Abstract][Full Text] [Related]
20. Driving toward precision medicine for B cell lymphomas: Targeting the molecular pathogenesis at the gene level.
Chung C
J Oncol Pharm Pract; 2020 Jun; 26(4):943-966. PubMed ID: 31964218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]